Citigroup
TWST icon

Citigroup’s Twist Bioscience TWST Stock Holding History

Citigroup’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,100
Closed -$38K – 6331
2022
Q2 		$38K Hold
1,100
– – ﹤0.01% 4666
2022
Q1 		$54K Buy
+1,100
New +$61K ﹤0.01% 4697
2021
Q1 		– Sell
-26,600
Closed -$3.76M – 7401
2020
Q4 		$3.76M Buy
26,600
+10,300
+63% +$1.14M ﹤0.01% 2298
2020
Q3 		$1.24M Buy
+16,300
New +$1.01M ﹤0.01% 3081

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citigroup's TWST Position: Q1 2026 in Review

Citigroup increased its Twist Bioscience (TWST) stake by 15% in Q1 2026, buying an estimated $2.65M and bringing the position to 460,287 shares worth $21.9M. The position accounts for 0.01% of the portfolio, ranked #1012.

Citigroup first reported a position in TWST in Q4 2018 and has held it in 30 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Citigroup held 460,287 shares of Twist Bioscience worth $21.9M as of Q1 2026.
  • Citigroup bought 59,005 Twist Bioscience shares in Q1 2026, an estimated $2.65M.
  • Twist Bioscience made up 0.01% of Citigroup's portfolio in Q1 2026, its #1012 holding.
  • Citigroup first reported a position in Twist Bioscience in Q4 2018 and has held it in 30 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.